iSBTc 23rd Annual Meeting

Annual Meeting Main Page   |   Program Purpose   |   Faculty   |   Schedule   |   Support Opportunities
Registration   |   Hotel   |   Abstracts   |   Award Information   |   Dates to Remember/Deadlines
CME Information   |   Supporters

October 31 - November 2, 2008
Westin Gaslamp Quarter Hotel
San Diego, CA

Schedule at a Glance (subject to change)

Friday, October 31
6:00 am - 6:00 pm Registration Open
7:00 am - 8:00 am Continental Breakfast
7:50 am - 8:00 am President's Welcome
Jon M. Wigginton, MD - Merck & Co., Inc.
8:00 am - 8:45 am Richard V. Smalley, MD, Memorial Lectureship
Giorgio Parmiani, MD - San Raffaele Foundation
8:45 am - 11:30 am Plenary Session: Enhancing Cancer Vaccines
Co-Chairs/
Invited Speakers: 		Glenn Dranoff, MD - Dana-Farber Cancer Institute
W. Martin Kast, PhD - University of Southern California
11:30 am - 1:00 pm Lunch with Poster Viewing
1:00 pm - 3:00 pm Plenary Session: Adoptive Transfer
Co-Chairs: Helen E. Heslop, MD - Baylor College of Medicine
William J. Murphy, PhD - University of Nevada, School of Medicine
Invited Speakers: Michael Jensen, MD - City of Hope, Beckman Research Institute
Nicholas P. Restifo, MD - National Cancer Institute
3:15 pm - 4:45 pm Concurrent Session I: TH-17, Cytokines and T Cell Subsets
Co-Chairs: Martin Oft - Schering-Plough Biopharma (formerly DNAX)
Hideaki Tahara, MD, PhD - University of Tokyo
Invited Speakers: Ilona Kryczek, PhD - University of Michigan
Martin Oft - Schering-Plough Biopharma (formerly DNAX)
Hideaki Tahara, MD, PhD - University of Tokyo
3:15 pm - 4:45 pm Concurrent Session II: Endpoints, Response Criteria for Clinical Trial Design
Co-Chairs: Thomas A. Davis, MD - Celldex Therapeutics, Inc.
Jeffrey Schlom, PhD - National Cancer Institute, NIH
Invited Speakers: TBA
TBA
4:45 pm - 5:15 pm Membership Business Meeting
5:15 pm - 7:00 pm Reception with Poster Viewing
   
Saturday, November 1
7:00 am - 6:00 pm Registration Open
7:00 am - 8:00 am Continental Breakfast
8:00 am - 8:45 am Keynote Address
Robert D. Schreiber, PhD - Washington University in St. Louis
8:45 am - 11:30 am Plenary Session: Tumor Escape / Tumor Microenvironment
Co-Chairs: Thomas F. Gajewski, MD, PhD - University of Chicago
Weiping Zou, MD, PhD - University of Michigan
Invited Speakers: Thomas F. Gajewski, MD, PhD - University of Chicago
Pierre van der Bruggen, PhD - Ludwig Institute for Cancer Research
Weiping Zou, MD, PhD - University of Michigan
11:30 am - 1:00 pm Lunch with Poster Viewing
1:00 pm - 2:20 pm iSBTc Presidential Session
Chair: Jon M. Wigginton, MD - Merck & Co., Inc.
2:45 pm - 4:15 pm Concurrent Session I: Tumor Targeting Monoclonal Antibodies
Co-Chairs: Helen Chen, MD - National Cancer Institute, CTEP
Greg Lazar, PhD - Xencor, Inc.
Invited Speakers: John C. Byrd, MD - The Ohio State University
John R. Desjarlais, PhD - Xencor, Inc.
2:45 pm - 4:15 pm Concurrent Session II: Innate Immunity to Tumors
Co-Chairs/
Invited Speakers: 		David Raulet, PhD - University of California, Berkeley
Giorgio Trinchieri, MD - National Cancer Institute
4:15 pm - 4:45 pm Award Presentations
4:45 pm - 6:30 pm Presidential Reception with Poster Viewing
   
Sunday, November 2
7:00 am - 11:00 am Registration Open
7:00 am - 8:00 am Continental Breakfast
8:00 am - 8:45 am Update: 2007 Workshop on Future Opportunities for Combination Biological
               Therapy of Cancer
Speaker: Jon M. Wigginton, MD - Merck & Co., Inc.
8:45 am - 11:00am Plenary Session: Cancer Stem Cell and the Host Response
Co-Chairs/
Invited Speakers: 		Madhav Dhodapkar, MD - The Rockefeller University
Max Wicha, MD - University of Michigan